The diseases listed in this rule and classified as "Class
A", "Class B", and "Class C" are declared to be
dangerous to the public health and are reportable. The occurrence of
cases or suspected cases of a disease classified as "Class A",
"Class B", or "Class C" shall be reported to the
board of health on forms as prescribed and provided by the director and
shall be reported in accordance with this rule and Chapter 3701-3 of the
Administrative Code.
(1) Diseases of major public health concern because of the severity
of disease or potential for
epidemic spread:
(a) Anthrax
(b) Botulism, foodborne;
(c) Cholera;
(d) Diphtheria;
(e) Measles;
(f) Meningococcal disease;
(g) Plague;
(h) Rabies, human;
(i) Rubella (not congenital);
(j) Smallpox;
(k) Any unexpected pattern of cases, suspected cases, deaths or
increased incidence of any other disease of major public health
concern, because of the severity of disease or potential for
epidemic spread, which may indicate a newly recognized infectious
agent, an outbreak, epidemic, related public health hazard or act of
bioterrorism.
(2) Diseases of public health concern needing timely response
because of potential for epidemic spread:
(a) Chancroid;
(b) Cyclosporiasis;
(c) Dengue;
(d) E. coli O157:H7 and
other enterohemorrhagic (shiga toxin-producing) e. COLI;
(e) Encephalitis, including arthropod-borne;
(f) Foodborne disease outbreaks;
(g) Granuloma inguinale;
(h) Haemophilus influenzae (invasive disease);
(i) Hantavirus;
(j) Hemolytic uremic syndrome;
(k) Hepatitis A;
(l) Legionnaires' disease;
(m) Listeriosis;
(n) Malaria;
(o) Meningitis, aseptic, including lymphocytic choriomeningitis
and viral meningoencephalitis;
(p) Mumps;
(q) Pertussis;
(r) Poliomyelitis (including vaccine-associated cases);
(s) Psittacosis;
(t) Q fever;
(u) Rubella, congenital;
(v) Salmonellosis;
(w) Shigellosis;
(x) Staphylococcus aureus, with resistance or intermediate
resistance to vancomycin (VISA, VRSA);
(y) Syphilis;
(z) Tetanus;
(aa) Tubercullosis, including multi-drug resistant tuberculosis (MDR-TB);
(bb) Typhoid fever;
(cc) Waterborne disease outbreaks;
(dd) Yellow fever.
(3) Diseases of significant public health concern:
(a) Amebiasis;
(b) Botulism;
(i) Wound;
(ii) Infant;
(c) Brucellosis;
(d) Campylobacteriosis;
(e) Chlamydia infections (nonspecific urethritis, cervicitis,
salpingitis, neonatal conjunctivitis, pneumonia, and lymphogranuloma
venereum);
(f) Creutzfeldt-Jakob disease;
(g) Cryptosporidiosis;
(h) Cytomegalovirus (congenital only);
(i) Ehrlichiosis;
(j) Encephalitis
(i) Other viral;
(ii) Post-infection;
(k) Giardiasis;
(l) Gonococcal infections;
(m) Hepatitis B including delta hepatitis;
(n) Hepatitis C;
(o) Hepatitis, acute viral, undeterminable etiology;
(p) Herpes (congenital only);
(q) Leprosy;
(r) Leptospirosis;
(s) Lyme disease;
(t) Meningitis, including other bacterial;
(u) Mucocutaneous lymph node syndrome (Kawasaki disease);
(v) Mycobacterial disease, other than tuberculosis;
(w) Pelvic inflammatory disease, gonococcal;
(x) Streptococcus pneumoniae, invasive disease;
(y) Reye syndrome;
(z) Rheumatic fever;
(aa) Rocky mountain spotted fever;
(bb) Streptococcal disease,
group A, invasive;
(cc) Streptococcal B in newborn;
(dd) Streptococcal toxic shock syndrome;
(ee) Toxic shock syndrome (T.S.S.);
(ff) Toxoplasmosis (congenital);
(gg) Trichinosis;
(hh) Tularemia;
(ii) Typhus fever;
(jj) Vancomycin resistant enterococcus;
(kk) Vibriosis; and
(ll) Yersiniosis.
(10) Outbreak, unusual incidence, or epidemic of other
infectious diseases of known etiology not categorized as Class A or
Class B or Class C.
